Taylor, Philip R.

Monocyte and macrophage heterogeneity

Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology

Immune cells in cancerAtherosclerosis and Cardiovascular Diseases

Cited by 5,190

Tissue-resident macrophages

Davies, L. C., Jenkins, S. J., Allen, J. E., & Taylor, P. R. (2013) · Nature Immunology

Immune cells in cancerPhagocytosis and Immune Regulation

Cited by 2,096

Detectable clonal mosaicism and its relationship to aging and cancer

Jacobs, K. B., Yeager, M., Zhou, W., Wacholder, S., Wang, Z., Rodriguez-Santiago, B., Hutchinson, A., Deng, X., Liu, C., Horner, M.-J., et al. (2012) · Nature Genetics

Cancer Genomics and DiagnosticsGenomic variations and chromosomal abnormalities

Cited by 589

The mannose receptor: linking homeostasis and immunity through sugar recognition

TAYLOR, P., GORDON, S., & MARTINEZPOMARES, L. (2005) · Trends in Immunology

Phagocytosis and Immune RegulationGlycosylation and Glycoproteins Research

Cited by 368

The Bioavailability to Humans of Ascorbic Acid from Oranges, Orange Juice and Cooked Broccoli Is Similar to That of Synthetic Ascorbic Acid

Mangels, A. R., Block, G., Frey, C. M., Patterson, B. H., Taylor, P. R., Norkus, E. P., & Levander, O. A. (1993) · The Journal of Nutrition

Vitamin C and Antioxidants ResearchPhytochemicals and Antioxidant Activities

Cited by 96

Terminal complement pathway activation drives synaptic loss in Alzheimer’s disease models

Carpanini, S. M., Torvell, M., Bevan, R. J., Byrne, R. A. J., Daskoulidou, N., Saito, T., Saido, T. C., Taylor, P. R., Hughes, T. R., Zelek, W. M., et al. (2022) · Acta Neuropathologica Communications

Alzheimer's disease research and treatmentsComplement system in diseases

Cited by 95

PIP2 depletion and altered endocytosis caused by expression of Alzheimer's disease‐protective variant PLCγ2 R522

Maguire, E., Menzies, G. E., Phillips, T., Sasner, M., Williams, H. M., Czubala, M. A., Evans, N., Cope, E. L., Sims, R., Howell, G. R., et al. (2021) · The EMBO Journal

Alzheimer's disease research and treatmentsCellular transport and secretion

Cited by 41

Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer’s disease

Jones, R. E., Andrews, R., Holmans, P., Hill, M., & Taylor, P. R. (2021) · Scientific Reports

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 39

Genetic Variants in Epidermal Growth Factor Receptor Pathway Genes and Risk of Esophageal Squamous Cell Carcinoma and Gastric Cancer in a Chinese Population

Li, W.-Q., Hu, N., Wang, Z., Yu, K., Su, H., Wang, L., Wang, C., Chanock, S. J., Burdett, L., Ding, T., et al. (2013) · PLoS ONE

Esophageal Cancer Research and TreatmentGenetic Associations and Epidemiology

Cited by 24

The Alzheimer’s disease protective P522R variant of PLCG2 , consistently enhances stimulus-dependent PLCγ2 activation, depleting substrate and altering cell function

Maguire, E., Menzies, G. E., Phillips, T., Sasner, M., Williams, H. M., Czubala, M. A., Evans, N., Cope, E. L., Sims, R., Howell, G. R., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory)

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 4

Abi3 regulates microglial ramification and dynamic tissue surveillance in vivo

Simonazzi, E., Jones, R. E., Chen, F., Ranson, A., Stevenson-Hoare, J., Escott-Price, V., Sengpiel, F., Morgan, B. P., & Taylor, P. R. (2021) · bioRxiv (Cold Spring Harbor Laboratory)

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 3

Alzheimer's Protection by PLCγ2 Compacts Plaques, Redistributes Microglia, and Protects Synapses in App NL ‐G‐F Mice

Bevan, R. J., Maguire, E., Mackinnon, E., Salis, E., Phillips, T., Simonazzi, E., Vassileva, M., Allen, N. D., Williams, J., & Taylor, P. R. (2026) · Glia

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 1